Who Owns CLDI?

Calidi Biotherapeutics, Inc. — Institutional Ownership & 13F Holdings

$0.22

+0.01 (+3.31%)

Market Cap

$2.6M

Shares Outstanding

7,366,994

Institutional Holders

36

Total Inst. Value

$3.1M

% of Float Held

99.2%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$1.9M3,322,000
2BANK OF MONTREAL /CAN/$277K489,800
3VANGUARD GROUP INC$200K353,380
4GEODE CAPITAL MANAGEMENT, LLC$142K251,916
5Belpointe Asset Management LLC$141K249,833
6HighTower Advisors, LLC$68K119,471
7CPR Investments Inc.$57K101,000
8Red Wave Investments LLC$46K80,828
9STATE STREET CORP$34K61,290
10RS CRUM INC.$31K55,313

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CLDI?

As of Q1 2025, 36 institutional investors report holding CLDI (Calidi Biotherapeutics, Inc.) in their 13F filings.

What percentage of Calidi Biotherapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 99.2% of Calidi Biotherapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CLDI?

The largest institutional holder of CLDI is ARMISTICE CAPITAL, LLC with $1.9M in shares.

Are institutions buying or selling CLDI?

This quarter, 13 institutions opened new positions in CLDI and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.